Skip to main navigation Skip to search Skip to main content

Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes

  • Joseph R. Rausch
  • , Korey K. Hood
  • , Alan Delamater
  • , Jennifer Shroff Pendley
  • , Jennifer M. Rohan
  • , Grafton Reeves
  • , Lawrence Dolan
  • , Dennis Drotar
  • Cincinnati Children's Hospital Medical Center
  • University of Miami
  • University of Cincinnati
  • Alfred I. duPont Hospital for Children

Research output: Contribution to journalArticlepeer-review

149 Scopus citations

Abstract

OBJECTIVE - To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS - We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9-11 years) to describe the mutual influences of glycemic control as measured by HbA 1c and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. RESULTS - HbA 1c increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA 1c. A change (increase) in HbA 1c was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. CONCLUSIONS - The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence.

Original languageEnglish
Pages (from-to)1219-1224
Number of pages6
JournalDiabetes Care
Volume35
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Dive into the research topics of 'Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes'. Together they form a unique fingerprint.

Cite this